Advertisement

Topics

Counsyl, Inc. Company Profile

21:29 EDT 24th September 2018 | BioPortfolio

Counsyl makes genetic testing simple, accessible, and useful for important medical decisions. The Counsyl Test won the Wall Street Journal’s Innovation Award for Medicine, was named one of Scientific American's "Top 10 World Changing Ideas" and was featured in the New York Times. It is now offered at thousands of medical centers nationwide and covered by many insurers. For more information, visit www.counsyl.com.


News Articles [13 Associated News Articles listed on BioPortfolio]

Myriad Genetics Signs Definitive Agreement to Acquire Counsyl

Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it has signed a definitive agreement to acquire Counsyl, a pioneer in expanded carrier...

Myriad Genetics acquires reproductive testing firm Counsyl for $375mm in cash and stock

Myriad Genetics Inc. agreed to acquire privately held Counsyl Inc., a DNA screening company focused on prenatal testing, women's health, and hereditary disorders.

Myriad Genetics to acquire health technology company, Counsyl for $375 million

Myriad Genetics, Inc., a leader in molecular diagnostics and personalised medicine, has signed a definitive agreement to acquire Counsyl, a pioneer in expanded carrier screening and non─invasive pre...

Myriad Genetics to buy genetic testing services provider Counsyl

Myriad Genetics has agreed to acquire genetic testing and DNA analysis services provider Counsyl in a deal worth around $375m.

Myriad Genetics to buy genetic testing and DNA analysis services provider Counsyl

Myriad Genetics has agreed to acquire genetic testing and DNA analysis services provider Counsyl in a deal worth around $375m.

Myriad Announces Closing of Counsyl Acquisition

SALT LAKE CITY, July 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, announced today that it has completed the acquisition of Counsyl, I...

Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc.

SALT LAKE CITY, May 28, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it has signed a definitive ag...

Counsyl to Offer Insight Into Streamlining Genetic Screening Into OBGYN Practice at the 2018 ACOG Annual Clinical and Scientific Meeting

Counsyl will also host a product theater titled “Addressing Patient Confusion Around Genetic Testing” Counsyl, a genetic screening company, will share insights into...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Counsyl

The Universal Genetic Test was developed by Counsyl, a Stanford startup founded by social entrepreneurs and philanthropists. Counsyl's mission is to end the needless suffering of ...

Counsyl, Inc.

Counsyl makes genetic testing simple, accessible, and useful for important medical decisions. The Counsyl Test won the Wall Street Journal’s Innovation Award for Medicine, wa...

More Information about "Counsyl, Inc." on BioPortfolio

We have published hundreds of Counsyl, Inc. news stories on BioPortfolio along with dozens of Counsyl, Inc. Clinical Trials and PubMed Articles about Counsyl, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Counsyl, Inc. Companies in our database. You can also find out about relevant Counsyl, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record